Trials of antiplatelet therapy
Bounameaux, H.
Bmj 308(6940): 1371-1372
1994
ISSN/ISBN: 0959-8138 PMID: 8019237 Document Number: 438758
Document emailed within 1 workday
Related Documents
Diener, H.C. 1997: Antiplatelet drugs in secondary prevention of stroke: lessons from recent trials Neurology 49(5 Suppl. 4): S75-S81Fake, A.; Ranchord, A.; Harding, S.; Larsen, P. 2017: Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review Current Cardiology Reviews 13(4): 325-333
Popova, L.V.; Aksenova, M.B.; Khlevchuk, T.V. 2016: Antiplatelet therapy in cardiology Klinicheskaia Meditsina 94(10): 729-736
Fernández-Meré, L.A.; Fernández Rogríguez, S.; Alvarez-Blanco, M. 2008: Stents, antiplatelet therapy, and surgery Revista Espanola de Anestesiologia y Reanimacion 55(3): 192-4; author reply 194
Brass, L.M. 2000: Antiplatelet therapy: a neurology perspective Managed Care 9(5 Suppl): 15-17
Hitzeman, N.; Applebaum, S. 2008: Oral anticoagulants vs. antiplatelet therapy American Family Physician 77(9): 1250-1252
Ahmad, S. 1984: Drug interactions complicate antiplatelet therapy Geriatrics 39(5): 137
Capodanno, D.; Angiolillo, D.J.; Tamburino, C. 2011: Antiplatelet and anticoagulant therapy in elderly patients Giornale Italiano di Cardiologia 12(3): 186-197
McGarry, J.; Bickerstaffe, R. 1987: Prevention of pre-eclampsia by early antiplatelet therapy Clinical and Experimental Obstetrics and Gynecology 14(3-4): 131-132
Griguer, R.P.; Brochier, M.; Raynaud, R. 1973: The place of fibrinolytic and antiplatelet-aggregation agents in therapy Annales de Cardiologie et d'Angeiologie 22(6): 461-472
Curry, W.J.; Chambers, C.E.; Curry, G.W.; Curry, E.W. 2018: The art of delivering evidence-based dual antiplatelet therapy Journal of Family Practice 67(12): 758-766
Tanahashi, N. 2014: Antiplatelet therapy for secondary prevention of cerebral infarction Nihon Rinsho. Japanese Journal of Clinical Medicine 72(7): 1270-1275
Kessler, S.; Kessler, D.; Frishman, W.H. 1999: Antiplatelet therapy: glycoprotein IIb/IIIa receptor antagonists Drugs of Today 35(6): 413-418
Albers, G.W.; Tijssen, J.G. 1999: Antiplatelet therapy: new foundations for optimal treatment decisions Neurology 53(7 Suppl 4: S25-S31
Clem, J.R.; Falls, S. 1998: Advances in antiplatelet therapy for acute coronary syndromes South Dakota Journal of Medicine 51(7): 233-234
Matsuoka, T.; Inoue, K.; Mizuno, K.; Kita, Y.; Nakanishi, S.; Asai, S.; Taoka, R.; Soda, T.; Terai, A. 2012: Heparin as bridging anticoagulant and antiplatelet therapy during the perioperative period Hinyokika Kiyo. Acta Urologica Japonica 58(5): 223-226
AbuRahma, A.F.; Boland, J.P.; Robinson, P.; Decanio, R. 1990: Antiplatelet therapy and carotid plaque hemorrhage and its clinical implications Journal of Cardiovascular Surgery 31(1): 66-70
Johnston, N.; Bergdahl, E.; Samnegard, A.; Kenttä, L.; Holm, A.; Petursson, P.; Bäck, M. 2018: ST-elevation myocardial infarction and dual antiplatelet therapy: new guidelines Lakartidningen 115
Bhatt, D.L.; Kapadia, S.R.; Bajzer, C.T.; Chew, D.P.; Ziada, K.M.; Mukherjee, D.; Roffi, M.; Topol, E.J.; Yadav, J.S. 2001: Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting Journal of Invasive Cardiology 13(12): 767-771
Zavalska, T.V. 2014: Antiplatelet Therapy Influence on Immunological Status of Progressive Angina Patients Likars'ka Sprava 2014(9-10): 43-46